A new trading day began on Friday, with Angiodynamic Inc (NASDAQ: ANGO) stock price down -5.08% from the previous day of trading, before settling in for the closing price of $7.09. ANGO’s price has ranged from $5.26 to $8.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.66% over the last five years. Meanwhile, its annual earnings per share averaged -5.61%. With a float of $38.64 million, this company’s outstanding shares have now reached $40.43 million.
The firm has a total of 748 workers. Let’s measure their productivity. In terms of profitability, gross margin is 49.71%, operating margin of -14.9%, and the pretax margin is -81.7%.
Angiodynamic Inc (ANGO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Angiodynamic Inc is 4.90%, while institutional ownership is 79.60%. The most recent insider transaction that took place on Oct 07 ’24, was worth 4,677. In this transaction SVP Quality and Regulatory of this company bought 768 shares at a rate of $6.09, taking the stock ownership to the 45,777 shares. Before that another transaction happened on Oct 10 ’24, when Company’s SVP Quality and Regulatory bought 100 for $6.08, making the entire transaction worth $608. This insider now owns 45,877 shares in total.
Angiodynamic Inc (ANGO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -5.61% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
Here are Angiodynamic Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.04, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Analysing the last 5-days average volume posted by the [Angiodynamic Inc, ANGO], we can find that recorded value of 0.78 million was better than the volume posted last year of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 70.72%. Additionally, its Average True Range was 0.35.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 47.91%, which indicates a significant decrease from 58.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.18% in the past 14 days, which was lower than the 65.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.15, while its 200-day Moving Average is $6.45. Now, the first resistance to watch is $7.00. This is followed by the second major resistance level at $7.27. The third major resistance level sits at $7.41. If the price goes on to break the first support level at $6.59, it is likely to go to the next support level at $6.44. Should the price break the second support level, the third support level stands at $6.17.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
With a market capitalization of 273.44 million, the company has a total of 40,055K Shares Outstanding. Currently, annual sales are 303,910 K while annual income is -184,350 K. The company’s previous quarter sales were 67,490 K while its latest quarter income was -12,800 K.
